[Animal experimental studies on the reactivity of stable cyclophosphamide metabolites in vivo]

[Floating thrombus of the internal carotid artery as a rare complication in ovarian hyperstimulation syndrome after in vitro fertilization/embryo transfer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·1998

[Synthesis of 14C-azelastine hydrochloride].

Arzneimittel-Forschung·1983

[Circulating immune complexes in bronchogenic carcinoma: relation to extent of disease and to therapy (author's transl)].

Klinische Wochenschrift·1979

In vitro sensitivity testing of cells of histologically typified ovarian carcinomas and carcinoma of corpus with 3H-cyclophosphamide-metabolites in the serum of man after massive dose therapy.

International journal of clinical pharmacology and biopharmacy·1978

[Tests of the sensitivity of histologically characterized carcinomas of the ovary or corpus to 4-hydroperoxicyclophosphamide, amethopterine, mitopodozide and VM-26 sandoz, using the technique of primary culture (author's transl)].

Strahlentherapie·1977

[Isoelectric focusing of an alkylating 3H-cyclophosphamide derivative from human bladder urine].

International journal of clinical pharmacology and biopharmacy·1976

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012

Fluorescence detection of etoposide-loaded nanoparticles by HPLC and pharmacokinetics study.

Arzneimittel-Forschung·2012

Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms.

Arzneimittel-Forschung·2012

Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

Environmental health perspectives·2026

Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.

Frontiers in pharmacology·2026

Screening Bacteriuria Using the Sysmex UF-5000 during Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer.

Chonnam medical journal·2026

Cannabis use and perceptions among rural and urban cancer patients and survivors from a Pennsylvania cancer center.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

BEHOLD-1 and -2: phase 1/2 randomized studies evaluating the B7 homolog 4 protein-targeted antibody-drug conjugate mocertatug rezetecan in patients with solid tumors, including endometrial and ovarian cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Selective cognitive changes in a multidrug mouse model of chemotherapy-induced adverse effects.

Brain research·2026

Related Experiment Videos

[Animal experimental studies on the reactivity of stable cyclophosphamide metabolites in vivo]

Related Concept Videos

[Floating thrombus of the internal carotid artery as a rare complication in ovarian hyperstimulation syndrome after in vitro fertilization/embryo transfer].

[Synthesis of 14C-azelastine hydrochloride].

[Circulating immune complexes in bronchogenic carcinoma: relation to extent of disease and to therapy (author's transl)].

In vitro sensitivity testing of cells of histologically typified ovarian carcinomas and carcinoma of corpus with 3H-cyclophosphamide-metabolites in the serum of man after massive dose therapy.

[Tests of the sensitivity of histologically characterized carcinomas of the ovary or corpus to 4-hydroperoxicyclophosphamide, amethopterine, mitopodozide and VM-26 sandoz, using the technique of primary culture (author's transl)].

[Isoelectric focusing of an alkylating 3H-cyclophosphamide derivative from human bladder urine].

Leave-one-out procedure in the validation of elimination rate constant analysis.

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Fluorescence detection of etoposide-loaded nanoparticles by HPLC and pharmacokinetics study.

Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms.

Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.

Screening Bacteriuria Using the Sysmex UF-5000 during Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer.

Cannabis use and perceptions among rural and urban cancer patients and survivors from a Pennsylvania cancer center.

BEHOLD-1 and -2: phase 1/2 randomized studies evaluating the B7 homolog 4 protein-targeted antibody-drug conjugate mocertatug rezetecan in patients with solid tumors, including endometrial and ovarian cancers.

Selective cognitive changes in a multidrug mouse model of chemotherapy-induced adverse effects.

Related Experiment Videos

[Animal experimental studies on the reactivity of stable cyclophosphamide metabolites in vivo]

Related Concept Videos

Related Articles